All posts tagged
A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa
Resetting the Immune System to Stop Multiple Sclerosis
Europe’s Largest Biotech Actelion Seals the Deal with J&J for €28B
An EU Project will tackle Multiple Sclerosis using Personalized Multi Omics
Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment
UPDATE: Novartis is Favoured to Win the Race for a New MS Drug
First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!
Sanofi-Genzyme: Still successful 5 years after the acquisition?
Labiotech UG, All Rights Reserved -
Send this to friend